Clinical Research Directory
Browse clinical research sites, groups, and studies.
Myeloma Novel Drug Discovery Ver 1.2
Sponsor: Institute of Cancer Research, United Kingdom
Summary
Myeloma is a bone marrow cancer with over 5000 patients diagnosed in the UK each year. Researchers are committed to improving understanding of myeloma and developing more effective treatments with fewer side effects in order to improve patient outcomes. In order to do this, researchers are collecting samples of blood and bone marrow to test the activity of potential new treatments in the laboratory and to understand what may be the cause of some treatments not working.
Official title: Investigation of the Activity of Novel Compounds for the Treatment of Myeloma and Mechanisms of Drug Resistance to Current Therapies
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
250
Start Date
2020-07-22
Completion Date
2035-02-28
Last Updated
2023-08-03
Healthy Volunteers
No
Conditions
Interventions
Observational study - sample collection only.
No intervention - blood and/or bone marrow sample collection only
Locations (1)
The Royal Marsden NHS Foundation Trust
Sutton, United Kingdom